Matthew J. Gardella

Member vCard


  • Boston University School of Law (JD)
  • Dartmouth College (BA)

Bar Admissions

  • Massachusetts

Matthew focuses his practice on corporate and securities law matters, with an emphasis on capital raising and mergers and acquisitions. He represents issuers, investors and investment banking firms in a broad range of capital market transactions, including initial public offerings, PIPEs, follow-on public equity and debt offerings, SPACs and private placements. In addition to transactional work, he counsels clients on compliance matters, the ongoing reporting requirements of publicly traded companies, corporate governance best practices and various other matters affecting publicly-traded companies and their officers and directors.

Matthew has served as counsel for clients engaged in a broad range of industries, including retail, technology, life sciences and media/telecommunications. He has advised companies with respect to spin-offs, exchange offers, tender offers, debt repurchases programs and stock buybacks.

Matthew has served as outside general counsel to a variety of publicly traded companies, including Spero Therapeutics, Synlogic, Molecular Templates, ATN International, Helix Technology Corporation, TECO Energy, Boston Communications Group, Inc. (bcgi), Dynasil Corporation of America and SofTech, Inc.

Representative Matters

Mergers & Acquisitions

  • Synlogic, Inc. in its merger with Mirna Therapeutics, Inc. (NASDAQ: MIRN)
  • Molecular Templates, Inc. in its merger with Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)
  • Synta Pharmaceuticals (NASDAQ: SNTA) in its merger with Madrigal Pharmaceuticals
  • Atlantic Tele-Network (NASDAQ: ATNI) in its $145 million acquisition of Innovative Group
  • Netsmart Technologies, Inc. in multiple acquisitions, including of HealthMEDX; Lavender & Wyatt Systems; Trend Consulting Services; Defran Systems; and Sequest Technologies
  • Essilor International SA in its $270 million acquisition of Costa Inc. (NASDAQ: ATX)
  • FGX International in its acquisition of Stylemark
  • ASSA ABLOY AB in its $80 million acquisition of LaserCard Corporation (NASDAQ: LCRD)
  • ABRY Partners, a private equity firm, in its $1.3 billion acquisition of RCN Corporation (NASDAQ: RCNI)
  • Cequent Pharmaceuticals in its sale to Marina Biotech, Inc. (NASDAQ: MRNAD), formerly known as MDRNA, Inc.
  • Dynasil Corporation of America (NASDAQ: DYSL) in its acquisition of Hilger Crystal Limited, a U.K. subsidiary of Newport Corp. (NASDAQ: NEWP)
  • Management team of Netsmart Technologies, Inc. in connection with the acquisition of Netsmart by private equity firm, Genstar Capital, including terms of management’s “roll-over” and co-investment arrangements and related employment and compensation arrangements
  • Takeda Pharmaceutical Company Limited (TSE:4502) in its $8.8 billion acquisition of Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM), one of the largest foreign acquisitions by a Japanese company, the largest by a Japanese company in the pharmaceutical industry and IDD magazine‘s “Healthcare Deal of the Year” in 2008
  • Lane, Berry & Co. International LLC in its sale to Raymond James Financial, Inc.
  • Netsmart Technologies, Inc. in its acquisition of the assets of the Therapist Helper Division from Nightingale Informatix Corporation (TSX-V:  NGH)
  • XIUS – bcgi in its sale of substantially all of its interests in its Israeli subsidiary, Puresight Technologies Limited
  • Boston Communications Group, Inc. (NASDAQ: BCGI) in its $65 million merger with Megasoft Limited
  • Helix Technology Corporation (NASDAQ: HELX) in its agreement to merge with Brooks Automation in a $450 million stock swap

Securities Offerings

  • Spero Therapeutics, Inc. in its $75 million follow-on offering
  • Synlogic, Inc. in its $30 million follow-on offering
  • Synlogic, Inc. in its $57.5 million follow-on offering
  • Spero Therapeutics, Inc. in its $83.6 million initial public offering
  • WAVE Life Sciences Ltd. in its $102 million initial public offering
  • Achillion Pharmaceuticals, Inc. in its $141.4 million follow-on offering (underwriters' counsel)
  • TECO Energy in its $280.5 million public offering of common stock
  • Stemline Therapeutics, Inc. in its $30 million initial public offering
  • Recapitalization transaction of SofTech, Inc.
  • Atlantic Tele-Network in its $68 million public offering of common stock
  • American Tower Corporation (NYSE: AMT), the leading independent operator of wireless and broadcast communications towers in North America, in numerous public equity and debt offerings and Rule 144A offerings
  • Lamar Advertising Company (NASDAQ: LAMR), the largest independent outdoor advertising company, in its $287.5 million convertible notes offering
  • Sheffield Steel, a leading regional producer of steel products, in its $80 million high-yield notes offering

Recognitions & Awards

  • Named Lawyer of the Year in the area of Corporate Compliance Law (Boston) by Best Lawyers in America (2018)
  • Best Lawyers in America: Corporate Compliance Law, Corporate Governance Law, Corporate Law  (2006 - 2019)
  • Named Lawyer of the Year in the area of Corporate Governance Law (Boston) by Best Lawyers in America (2017)
  • Recommended by The Legal 500 United States for M&A: Middle-Market (2017)

Professional & Community Involvement

  • Co-chair, Securities Law Committee, Boston Bar Association (2005 - 2007)
  • Member, Board of Overseers, Boys & Girls Club of Boston (2007 - 2013)
  • Trustee, South Kent School (2009-2014)
  • Former elected member of Waban Area Council in Waban, Massachusetts

Create PDF


  • Publications
    • Alerts & Advisories
    • Industry Reports & Newsletters
    • Published Articles
  • Speaking Engagements
  • Newsroom
    • Press Releases
    • In The News